Senior insider sale
Chief Clinical Officer at PACIRA BIOSCIENCES, INC. — senior position signals high conviction
$74.4K
3.26K shares
What this filing means
SLONIN JONATHAN plans to sell 3.26K shares of PACIRA BIOSCIENCES, INC. valued at approximately $74.4K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/17/2026ACC: 0001959173-26-002402
Officer· Chief Clinical Officer
Since Jul 2021
3.26K
Shares to sell
$74.4K
Approx. market value
3.26K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months3
Restricted Stock Vesting
Compensation
6/3/2022
1.05KStock Option Exercise
Cash
5/23/2022
2KESPP Purchase
Cash
12/31/2021
209.00Total acquired3.26K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/3/2022 | Restricted Stock Vesting Compensation | 1.05K | — |
5/23/2022 | Stock Option Exercise Cash | 2K | — |
12/31/2021 | ESPP Purchase Cash | 209.00 | — |
| Total | 3.26K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
3.26K
Market value
$74.4K
3/17/2026
Total
Units
3.26K
Value
$74.4K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
3/17/2026 | 3.26K | $74.4K | NASDAQ | Planned |
| Total | 3.26K | $74.4K | ||